Certified by Founder Lodge
Curve Therapeutics
United Kingdom - Southampton, Hants START UP
1 Disclosed Funding Rounds $51,183,495
0 Participating Investments
- Founded date
2019
- Operating Status
Active
- Last Funding Type
Seed
- Company Type
For Profit
- Website
- Contact
- Social Links
Our mission is to transform the discovery of first-in-class small molecule therapeutics by broadening the landscape of disease targets that can be drugged.
Our Microcycle® platform enable
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 28 ,2024 | Series A | $51,183,495 |
Pfizer
Advent Life Sciences
British Patient Capital
Epidarex Capital
COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U.
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Further AI | $5,000,000 | (Apr 3, 2025)
SchoolAI | $25,000,000 | (Apr 3, 2025)
Vivere | $7,500,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
TwinKnowledge | $3,700,000 | (Apr 3, 2025)
